Pharmacist check prevents cancer drug Mix-Ups
NCT ID NCT04142567
First seen Mar 08, 2026 · Last updated Apr 28, 2026 · Updated 11 times
Summary
This study tested whether having a pharmacist review medications before cancer treatment starts can prevent drug-related problems, like harmful interactions. Researchers observed 440 adults with solid tumors who were about to begin chemotherapy, immunotherapy, or oral targeted therapy. The goal was to see how often the pharmacist's advice led to changes in treatment to avoid risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP -Cochin Hospital and Georges Pompidou European Hospital
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.